ClinicalTrials.Veeva

Menu

Medical Abortion With Single Daily Dose of Misoprostol

A

Ain Shams University

Status and phase

Completed
Phase 3
Phase 2

Conditions

Miscarriage

Treatments

Drug: Misoprostol

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Medical abortion using multiple vs single daily dose of misoprostol in first trimester miscarriage.

Enrollment

200 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Maternal age more than 18 years old (age of legal consent).
  • Gestational age less than 13 weeks.
  • Hemoglobin >10 g/dL.
  • BMI between 25 kg/m2 and 35 kg/m2.
  • Missed abortion.
  • Living fetus with multiple congenital malformations incompatible with life.

Exclusion criteria

  • Maternal age less than 18 years old.
  • Gestational age more than 12 weeks.
  • Hemoglobin <10 g/dL.
  • Anencephaly.
  • Fibroid uterus.
  • BMI less than 25kg/m2 and more than 35kg/m2.
  • Coagulopathy.
  • History or evidence of adrenal pathology.
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or letrozole.
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

200 participants in 2 patient groups

Single daily dose
Active Comparator group
Treatment:
Drug: Misoprostol
Multiple daily doses
Active Comparator group
Treatment:
Drug: Misoprostol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems